Evidence map›Paper›PMID 42352429›Full record

ReviewCancers2026

Tumors of the Lacrimal Drainage System: Diagnosis and Management.

Ernest Iakovlev, Kaveh Vahdani, David H Verity, Simon Gane, Geoffrey E Rose

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ernest IakovlevOrbital Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
Kaveh VahdaniOrbital Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
David H VerityOrbital Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
Simon GaneOrbital Service, Moorfields Eye Hospital, London EC1V 2PD, UK.ORCID 0000-0002-0356-8190
Geoffrey E RoseOrbital Service, Moorfields Eye Hospital, London EC1V 2PD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumors of the lacrimal drainage system are rare and include benign and malignant variants. Their presentation frequently mimics inflammatory or obstructive lacrimal disease, which often results in delayed diagnosis and diagnostic uncertainty. A high index of suspicion, appropriate imaging, and timely biopsy are required to verify the histology and guide management. Surgical excision remains the cornerstone of treatment for most lesions, with the aim of achieving histologically clear margins. Advances in endoscopic and combined surgical approaches have enabled radical tumor resection whilst reducing morbidity and improving globe preservation. Adjuvant radiotherapy is commonly employed in malignant disease, while systemic chemotherapy, immunotherapy, and targeted therapies may be considered in selected advanced or recurrent cases. Emerging molecular insights and evolving surgical techniques may further refine future treatment strategies. This review summarizes current evidence and clinical principles to provide a practical framework for the diagnosis and management of lacrimal drainage system tumors.

Indexed as

dacryocystitisepiphoralacrimal drainage systemlacrimal saclacrimal sac tumorsnasolacrimal ductorbittumor

Identifiers

PMID42352429
PMCPMC13296775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.